Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The history now includes a new Revision: v3.6.3 entry, updating the page to the latest revision and replacing the previous v3.6.2 entry.
    Difference
    0.0%
    Check dated 2026-07-05T15:27:29.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label was updated from v3.6.0 to v3.6.2, indicating a newer site revision. No study data or functionality changes are evident.
    Difference
    0.0%
    Check dated 2026-06-28T08:37:28.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants'. A new Revision: v3.6.0 entry was added and the previous Revision: v3.5.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-06-14T05:07:41.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision label in the page footer updated from v3.5.4 to v3.5.5. This reflects a newer site revision.
    Difference
    0.0%
    Check dated 2026-06-06T23:37:34.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A new version entry (210) was added, updating the Study Status and Arms and Interventions sections and applying revision v3.5.4; this follows the prior revision v3.5.3.
    Difference
    0.2%
    Check dated 2026-05-16T10:12:12.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The page’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T05:32:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.